Table 3 The predictors for eGFR improvement at the end of 3-years of treatment with LdT and ETV compared with baseline
Univariate logistic regression | Multivariate logistic regression | |||||
|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age | 0.99 | 0.96–1.03 | 0.75 | 0.98 | 0.94–1.03 | 0.48 |
Sex | 0.77 | 0.26–2.22 | 0.62 | 1.09 | 0.28–4.21 | 0.90 |
LdT | 6.67 | 2.37–18.8 | 0.0001 | 7.97 | 2.47–25.7 | 0.001 |
HBV DNA | 1 | 1 | 0.83 | 1 | 1 | 0.26 |
HBeAg | 0.50 | 0.20–1.27 | 0.13 | 0.33 | 0.09–1.24 | 0.10 |
Baseline eGFR | 0.98 | 0.96–1.00 | 0.067 | 0.98 | 0.96–1.00 | 0.08 |
Nephrotoxic agents | 1.70 | 0.36–8.15 | 0.51 | 1.15 | 0.17–7.61 | 0.89 |